LV10183A - Perorala kompozicija zarnu iekaisuma slimibu arstesanai - Google Patents

Perorala kompozicija zarnu iekaisuma slimibu arstesanai

Info

Publication number: LV10183A
Authority: LV; Latvia
Prior art keywords: treatment; perorala; composition; inflammatory bowel; bowel disease
Prior art date: 1989-11-22

Application number

LV931026A

Other languages

English (en)

Other versions

LV10183B (en

Inventor

Jan Ulmius

Original Assignee

Draco Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-22

Filing date

1993-08-10

Publication date

1994-10-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV10183(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-08-10 Application filed by Draco Ab filed Critical Draco Ab

1994-10-20 Publication of LV10183A publication Critical patent/LV10183A/lv

1995-08-20 Publication of LV10183B publication Critical patent/LV10183B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Ultra Sonic Daignosis Equipment (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)

LVP-93-1026A 1989-11-22 1993-08-10 Oral composition for the treatment of inflammatory bowel diseases LV10183B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE8903914A SE8903914D0 (sv)	1989-11-22	1989-11-22	Oral composition for the treatment of inflammatory bowel diseases
PCT/SE1990/000738 WO1991007172A1 (en)	1989-11-22	1990-11-15	Oral composition for the treatment of inflammatory bowel diseases

Publications (2)

Publication Number	Publication Date
LV10183A true LV10183A (lv)	1994-10-20
LV10183B LV10183B (en)	1995-08-20

Family

ID=20377544

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LVP-93-1026A LV10183B (en)	1989-11-22	1993-08-10	Oral composition for the treatment of inflammatory bowel diseases

Country Status (36)

Country	Link
US (1)	US6423340B1 (lv)
EP (1)	EP0502092B1 (lv)
JP (1)	JP3145111B2 (lv)
KR (1)	KR0179042B1 (lv)
AT (1)	ATE125445T1 (lv)
AU (1)	AU643021B2 (lv)
CA (1)	CA2071518C (lv)
DE (1)	DE69021214T2 (lv)
DK (1)	DK0502092T3 (lv)
EG (1)	EG19642A (lv)
ES (1)	ES2074698T3 (lv)
FI (2)	FI104949B (lv)
GR (1)	GR3017691T3 (lv)
HK (1)	HK51897A (lv)
HR (1)	HRP920632B1 (lv)
HU (2)	HUT60630A (lv)
IE (1)	IE74854B1 (lv)
IL (1)	IL96415A (lv)
IS (1)	IS1858B (lv)
LT (1)	LT3696B (lv)
LV (1)	LV10183B (lv)
MY (1)	MY104535A (lv)
NO (1)	NO304010B1 (lv)
NZ (1)	NZ235807A (lv)
PL (1)	PL166506B1 (lv)
PT (1)	PT95946A (lv)
RU (1)	RU2134104C1 (lv)
SA (1)	SA90110123B1 (lv)
SE (1)	SE8903914D0 (lv)
SG (1)	SG54210A1 (lv)
SI (1)	SI9012150A (lv)
TW (1)	TW250435B (lv)
UA (1)	UA37196C2 (lv)
WO (1)	WO1991007172A1 (lv)
YU (1)	YU48583B (lv)
ZA (1)	ZA908777B (lv)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5316772A (en) *	1990-12-19	1994-05-31	Solvay & Cie, S.A. (Societe Anonyme)	Bilayered oral pharmaceutical composition with pH dependent release
KR960700266A (ko) *	1993-01-08	1996-01-19	클래스 빌헬름슨	신규 결장- 또는 회장-특이성 스테로이드 유도체(Novel Colon-or lleum-Specific Steroid Derivatives)
US5914132A (en) *	1993-02-26	1999-06-22	The Procter & Gamble Company	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) *	1993-09-23	1995-03-30	Falk Pharma Gmbh	Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) *	1995-05-17	1997-11-11	The Procter & Gamble Company	Pharmaceutical dosage form for colonic delivery
AU739031B2 (en) *	1996-11-15	2001-10-04	Procter & Gamble Company, The	Pharmaceutical dosage form for colonic delivery
SE9604751D0 (sv)	1996-12-20	1996-12-20	Astra Ab	New therapy
DE19732903A1 (de)	1997-07-30	1999-02-04	Falk Pharma Gmbh	Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en)	1998-03-17	2001-05-29	Pharmalink Ab	Method and means for treating glomerulonephritis
GB9824604D0 (en)	1998-11-11	1999-01-06	Hewlett Healthcare Limited	Treatment of allergic conditions
SE9902673D0 (sv) *	1999-07-12	1999-07-12	Astra Ab	New composition
EP1392321B1 (en) *	2001-03-15	2010-08-18	Soligenix, Inc.	Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
DE10250543A1 (de) *	2002-10-29	2004-05-19	Röhm GmbH & Co. KG	Mehrschichtige Arzneiform
EP1572217B1 (en)	2002-12-12	2008-08-20	Nycomed GmbH	Combination medicament of r,r-formoterol and ciclesonide
WO2004087109A1 (ja) *	2003-03-27	2004-10-14	Hisamitsu Pharmaceutical Co., Inc.	大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
AU2004271743B2 (en) *	2003-09-15	2010-06-10	Covis Pharma B.V.	Use of ciclesonide for the treatment of inflammatory bowel diseases
ES2452691T5 (es)	2003-09-16	2022-09-14	Covis Pharma Gmbh	Uso de ciclesonida para el tratamiento de enfermedades respiratorias
CA2570916C (en)	2004-06-16	2013-06-11	Tap Pharmaceutical Products, Inc.	Pulsed release dosage form of a ppi
WO2007056539A2 (en) *	2005-11-08	2007-05-18	Medarex, Inc.	Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
JPWO2008117814A1 (ja) *	2007-03-26	2010-07-15	帝國製薬株式会社	大腸送達用経口製剤
EP2203068A4 (en) *	2007-10-12	2012-08-22	Takeda Pharmaceuticals Usa Inc	METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES INDEPENDENT FROM FOOD STORAGE
GB0808537D0 (en) *	2008-05-12	2008-06-18	Archimedes Dev Ltd	Compositions
CN102238868A (zh) *	2008-10-03	2011-11-09	福尔克博士药物有限责任公司	使用颗粒状5-氨基水杨酸治疗肠病的组合物和方法
US8945616B2 (en) *	2009-02-17	2015-02-03	Mylan Pharmaceuticals Inc.	Controlled release budesonide minitablets
US8945615B2 (en) *	2009-02-17	2015-02-03	Mylan Pharmaceuticals Inc.	Controlled release budesonide minitablets
PE20140887A1 (es) *	2011-02-04	2014-08-14	Optimer Pharmaceuticals Inc	Tratamiento de infecciones bacterianas
MD480Z5 (ro) *	2011-07-07	2012-09-30	Эльвира АНДОН	Metodă de tratament al colitei ulceroase nespecifice acute
DK2659881T3 (en)	2012-04-30	2018-02-05	Tillotts Pharma Ag	Delayed release drug formulation
WO2015062640A1 (en)	2013-10-29	2015-05-07	Tillotts Pharma Ag	A delayed release drug formulation
JP2018530535A (ja) *	2015-09-11	2018-10-18	サン・ファーマシューティカル・インダストリーズ・リミテッド	ブデゾニドの経口医薬剤形
CN105663091A (zh) *	2016-01-28	2016-06-15	上海信谊百路达药业有限公司	一种布地奈德肠溶缓释胶囊及其制备方法
WO2017138878A1 (en) *	2016-02-09	2017-08-17	Albireo Ab	Oral cholestyramine formulation and use thereof
CA3011565C (en) *	2016-02-09	2024-01-02	Albireo Ab	Oral cholestyramine formulation and use thereof
EP3613414A1 (de)	2018-08-24	2020-02-26	Dr. Falk Pharma Gmbh	Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en)	2022-01-24	2024-02-13	Calliditas Therapeutics Ab	Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3996356A (en)	1969-07-02	1976-12-07	Hoffmann-La Roche Inc.	Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (lv)	1972-05-19	1975-08-18	Bofors Ab
SE7813246L (sv)	1978-12-22	1980-06-23	Haessle Ab	Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr)	1979-12-10	1981-06-19	Roussel Uclaf	Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv)	1980-05-21	1981-11-22	Haessle Ab	En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv)	1980-12-04	1982-06-05	Draco Ab	4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en)	1981-07-31	1983-05-25	Tillott J B Ltd	Orally administrable pharmaceutical compositions
SE8306370D0 (sv)	1983-11-18	1983-11-18	Draco Ab	Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en)	1983-12-19	1987-11-24	Key Pharmaceuticals, Inc.	Minipellets
US4606940A (en)	1984-12-21	1986-08-19	The Ohio State University Research Foundation	Small particle formation and encapsulation
DE3536267A1 (de)	1985-10-11	1987-04-16	Bayer Ag	Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv)	1985-12-19	1985-12-19	Draco Ab	Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) *	1986-12-24	1987-02-04	Glaxo Group Ltd	Pharmaceutical compositions
US4966770A (en)	1989-07-26	1990-10-30	Himedics, Inc.	Prednisone microencapsulated granules
DE10307386A1 (de)	2003-02-21	2004-09-09	Dieter Wildfang Gmbh	Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

1989
- 1989-11-22 SE SE8903914A patent/SE8903914D0/xx unknown
1990
- 1990-10-24 NZ NZ235807A patent/NZ235807A/xx unknown
- 1990-11-01 ZA ZA908777A patent/ZA908777B/xx unknown
- 1990-11-07 SA SA90110123A patent/SA90110123B1/ar unknown
- 1990-11-07 TW TW079109396A patent/TW250435B/zh active
- 1990-11-13 YU YU215090A patent/YU48583B/sh unknown
- 1990-11-13 SI SI9012150A patent/SI9012150A/sl unknown
- 1990-11-15 WO PCT/SE1990/000738 patent/WO1991007172A1/en not_active Ceased
- 1990-11-15 SG SG1996004385A patent/SG54210A1/en unknown
- 1990-11-15 DE DE69021214T patent/DE69021214T2/de not_active Revoked
- 1990-11-15 ES ES91900414T patent/ES2074698T3/es not_active Expired - Lifetime
- 1990-11-15 HU HU9201700A patent/HUT60630A/hu unknown
- 1990-11-15 DK DK91900414.3T patent/DK0502092T3/da active
- 1990-11-15 AU AU77864/91A patent/AU643021B2/en not_active Expired
- 1990-11-15 AT AT91900414T patent/ATE125445T1/de not_active IP Right Cessation
- 1990-11-15 CA CA002071518A patent/CA2071518C/en not_active Expired - Lifetime
- 1990-11-15 EP EP91900414A patent/EP0502092B1/en not_active Revoked
- 1990-11-15 UA UA94051483A patent/UA37196C2/uk unknown
- 1990-11-15 JP JP50070991A patent/JP3145111B2/ja not_active Expired - Lifetime
- 1990-11-15 US US09/159,301 patent/US6423340B1/en not_active Expired - Fee Related
- 1990-11-15 KR KR1019920701202A patent/KR0179042B1/ko not_active Expired - Lifetime
- 1990-11-15 RU SU5052239A patent/RU2134104C1/ru active
- 1990-11-15 HU HU9201700A patent/HU216836B/hu unknown
- 1990-11-20 PL PL90287844A patent/PL166506B1/pl unknown
- 1990-11-20 IE IE417090A patent/IE74854B1/en not_active IP Right Cessation
- 1990-11-20 IL IL9641590A patent/IL96415A/en active IP Right Review Request
- 1990-11-20 EG EG69190A patent/EG19642A/xx active
- 1990-11-21 PT PT95946A patent/PT95946A/pt not_active Application Discontinuation
- 1990-11-21 MY MYPI90002053A patent/MY104535A/en unknown
- 1990-11-21 IS IS3644A patent/IS1858B/is unknown
1992
- 1992-05-21 NO NO922004A patent/NO304010B1/no not_active IP Right Cessation
- 1992-05-21 FI FI922325A patent/FI104949B/fi active
- 1992-09-30 HR HRP-2150/90A patent/HRP920632B1/xx not_active IP Right Cessation
1993
- 1993-08-10 LV LVP-93-1026A patent/LV10183B/en unknown
- 1993-12-31 LT LTIP1751A patent/LT3696B/lt not_active IP Right Cessation
1995
- 1995-10-11 GR GR950402797T patent/GR3017691T3/el unknown
1997
- 1997-04-24 HK HK51897A patent/HK51897A/en not_active IP Right Cessation
1999
- 1999-09-06 FI FI19991893A patent/FI19991893A7/fi unknown

Also Published As

Publication number	Publication date
EP0502092B1 (en)	1995-07-26
IE904170A1 (en)	1991-05-22
IS3644A7 (is)	1991-05-23
EP0502092A1 (en)	1992-09-09
FI19991893L (fi)	1999-09-06
DE69021214T2 (de)	1996-01-04
ATE125445T1 (de)	1995-08-15
RU2134104C1 (ru)	1999-08-10
HRP920632B1 (en)	1999-10-31
GR3017691T3 (en)	1996-01-31
PL287844A1 (en)	1991-12-02
EG19642A (en)	1995-08-30
IL96415A0 (en)	1991-08-16
NO922004D0 (no)	1992-05-21
AU7786491A (en)	1991-06-13
YU215090A (sr)	1996-01-09
ES2074698T3 (es)	1995-09-16
IE74854B1 (en)	1997-08-13
WO1991007172A1 (en)	1991-05-30
HK51897A (en)	1997-05-02
KR0179042B1 (ko)	1999-03-20
FI104949B (fi)	2000-05-15
LTIP1751A (en)	1995-07-25
LV10183B (en)	1995-08-20
ZA908777B (en)	1991-07-31
IS1858B (is)	2003-03-27
JPH05501705A (ja)	1993-04-02
NO922004L (no)	1992-05-21
MY104535A (en)	1994-04-30
DE69021214D1 (de)	1995-08-31
FI922325A0 (fi)	1992-05-21
SA90110123B1 (ar)	1999-06-06
US6423340B1 (en)	2002-07-23
FI19991893A7 (fi)	1999-09-06
DK0502092T3 (da)	1995-12-27
JP3145111B2 (ja)	2001-03-12
PL166506B1 (pl)	1995-05-31
YU48583B (sh)	1998-12-23
SE8903914D0 (sv)	1989-11-22
PT95946A (pt)	1991-09-13
CA2071518A1 (en)	1991-05-23
IL96415A (en)	1995-11-27
HU216836B (hu)	1999-09-28
LT3696B (en)	1996-02-26
UA37196C2 (uk)	2001-05-15
CA2071518C (en)	2002-11-12
NO304010B1 (no)	1998-10-12
HU9201700D0 (en)	1992-08-28
KR920703025A (ko)	1992-12-17
AU643021B2 (en)	1993-11-04
HUT60630A (en)	1992-10-28
HRP920632A2 (en)	1995-04-30
TW250435B (lv)	1995-07-01
SI9012150A (sl)	1998-08-31
SG54210A1 (en)	1998-11-16
FI922325L (fi)	1992-05-21
NZ235807A (en)	1993-02-25

Publication	Publication Date	Title
LV10183A (lv)	1994-10-20	Perorala kompozicija zarnu iekaisuma slimibu arstesanai
KR920002144A (ko)	1992-02-28	아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
ITRM910922A1 (it)	1993-06-11	Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
ZA899176B (en)	1990-09-26	Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
NO821832L (no)	1982-12-06	Fremgangsmaate for fremstilling av allergenholdige kapsler
ATE232396T1 (de)	2003-02-15	Oxydiertes thymosin beta 4
KR950700749A (ko)	1995-02-20	2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
EP0151989A3 (en)	1986-10-08	Means for the treatment of cardiac diseases
DE3875866D1 (de)	1992-12-17	Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
NO894222L (no)	1990-04-26	Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
FR2784897B1 (fr)	2002-11-29	Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
NO983177L (no)	1998-07-10	Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
MD990258A (en)	2001-07-31	Method of treatment of the acute viral hepatitis B
ATE199641T1 (de)	2001-03-15	Terpenderivate (sarcodictyine) als antikrebsmittel
NO960545D0 (no)	1996-02-12	Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
KR900017599A (ko)	1990-12-19	종양 치료용 약학 조성물
ATE36333T1 (de)	1988-08-15	Hydantoin enthaltende therapeutische mittel.
EP0621789A4 (en)	1995-09-06	Pharmaceutical pentapeptide compositions and methods of use thereof.
DE3676806D1 (de)	1991-02-14	Pharmazeutische zusammensetzung und behandlung.
RU99107944A (ru)	2001-02-20	Лечебное средство прямого антикоагулянтного и фибринолитического действия
ATE74767T1 (de)	1992-05-15	Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
MX9710126A (es)	1998-07-31	Compuestos sustituidos con sulfonamida, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que los contienen.
IT1264428B1 (it)	1996-09-23	Composizioni farmaceutiche per il trattamento della psoriasi
ITMI911930A1 (it)	1993-01-12	Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico.
ITRM940505A0 (it)	1994-07-28	"agente attivo per il trattamento di infezioni croniche da immunodepressione e per contrastare lo sviluppo di tumori favoriti da immunodepressione".